Lido Advisors LLC Sells 5,220 Shares of The Clorox Company $CLX

Lido Advisors LLC decreased its position in The Clorox Company (NYSE:CLXFree Report) by 34.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 9,871 shares of the company’s stock after selling 5,220 shares during the quarter. Lido Advisors LLC’s holdings in Clorox were worth $1,083,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after acquiring an additional 514 shares during the last quarter. Woodline Partners LP grew its holdings in Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after acquiring an additional 7,465 shares during the last quarter. Baird Financial Group Inc. grew its holdings in Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after acquiring an additional 424 shares during the last quarter. Jump Financial LLC grew its holdings in Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after acquiring an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia grew its holdings in Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after acquiring an additional 3,352 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 3.6%

Clorox stock opened at $98.54 on Wednesday. The company’s 50 day simple moving average is $96.74 and its 200 day simple moving average is $105.31. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The firm has a market capitalization of $11.92 billion, a price-to-earnings ratio of 16.00, a PEG ratio of 0.49 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% on a year-over-year basis. During the same period last year, the company posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 5.61 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on CLX. Evercore reissued an “underperform” rating and set a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 price objective on shares of Clorox in a report on Friday, May 1st. Finally, Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $103.40.

Get Our Latest Research Report on Clorox

Insider Buying and Selling

In related news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.63% of the company’s stock.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.